Latest filing published 05 Mar 2024 for Dyne Therapeutics, Inc., €476k.
Filing timeline
BuySaleInsider track record
Atlas Venture Opportunity Fund I, L.P.: trading record in brief
Atlas Venture Opportunity Fund I, L.P. has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Dyne Therapeutics, Inc., Akero Therapeutics, Inc. and Day One Biopharmaceuticals, Inc. Between 7 February 2020 and 1 March 2024, the trades on record add up to 4 filings.
Every open-market trade on record is a sale: 2 sales worth €1.3M. So far in 2024, the count stands at no purchases and 2 sales.
The record was last updated on 5 March 2024 with an open-market sale (€476k) in Dyne Therapeutics, Inc. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Atlas Venture Opportunity Fund I, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 17,099 shares@ US$30.05100.0% of flowCommon StockSEC:0001415889-24-006764:1
- ▼
Same trade as the filing by Jason P. Rhodes, counted once
884,522 USD28SEC29,435 shares@ US$30.05100.0% of flowCommon StockSEC:0001415889-24-006764:0 - 198,280 shares0Common StockSEC:0001209191-22-041171:0
- 50,510 shares0Common StockSEC:0001209191-20-008127:0
4 of 3 declarations
